PHARMACIE CONCHE-THOMAS : revenue, balance sheet and financial ratios

PHARMACIE CONCHE-THOMAS is a French company founded 20 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LE TOUVET (38660), this company of category PME shows in 2019 a revenue of 2.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE CONCHE-THOMAS (SIREN 489621623)
Indicator 2025 2024 2023 2022 2021 2020 2019 2017
Revenue N/C N/C N/C N/C N/C N/C 2 057 123 € 1 994 542 €
Net income 155 816 € 279 532 € 118 766 € 243 449 € 207 101 € 155 366 € 166 680 € 142 059 €
EBITDA N/C N/C N/C N/C N/C N/C 218 822 € 207 523 €
Net margin N/C N/C N/C N/C N/C N/C 8.1% 7.1%

Revenue and income statement

In 2025, PHARMACIE CONCHE-THOMAS generates positive net income of 156 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 142 k€ -> 156 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

155 816 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 539%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 16%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

539.216%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

15.629%

Solvency indicators evolution
PHARMACIE CONCHE-THOMAS

Sector positioning

Debt ratio
539.22 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Watch +50 pts over 3 years

In 2025, the debt ratio of PHARMACIE CONCHE-THOMAS (539.22) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
15.63% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch -51 pts over 3 years

In 2025, the financial autonomy of PHARMACIE CONCHE-THOMAS (15.6%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 6514.35. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

6514.347

Liquidity indicators evolution
PHARMACIE CONCHE-THOMAS

Sector positioning

Liquidity ratio
6514.35 2025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent

In 2025, the liquidity ratio of PHARMACIE CONCHE-THOMAS (6514.35) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE CONCHE-THOMAS

Positioning of PHARMACIE CONCHE-THOMAS in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE CONCHE-THOMAS is estimated at 2 475 155 € (range 1 679 652€ - 3 883 860€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1679k€ 2475k€ 3883k€
2 475 155 € Range: 1 679 652€ - 3 883 860€
NAF 5 année 2025

Valuation method used

Net Income Multiple
155 816 € × 15.9x = 2 475 156 €
Range: 1 679 652€ - 3 883 860€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE CONCHE-THOMAS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE CONCHE-THOMAS

What is the revenue of PHARMACIE CONCHE-THOMAS ?

The revenue of PHARMACIE CONCHE-THOMAS in 2019 is 2.1 M€.

Is PHARMACIE CONCHE-THOMAS profitable?

Yes, PHARMACIE CONCHE-THOMAS generated a net profit of 156 k€ in 2025.

Where is the headquarters of PHARMACIE CONCHE-THOMAS ?

The headquarters of PHARMACIE CONCHE-THOMAS is located in LE TOUVET (38660), in the department Isere.

Where to find the tax return of PHARMACIE CONCHE-THOMAS ?

The tax return of PHARMACIE CONCHE-THOMAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE CONCHE-THOMAS operate?

PHARMACIE CONCHE-THOMAS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.